Kazia Therapeutics Ltd (KZIA)
0.2901
-0.01
(-2.88%)
USD |
NASDAQ |
May 02, 14:47
Kazia Therapeutics Revenue (TTM)
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| June 30, 2019 | 0.0005M |
| December 31, 2018 | 0.1107M |
| June 30, 2018 | |
| December 31, 2017 | |
| June 30, 2017 | |
| December 31, 2016 | |
| June 30, 2016 | |
| December 31, 2015 | |
| June 30, 2015 | |
| December 31, 2014 | |
| June 30, 2014 |
| Date | Value |
|---|---|
| December 31, 2013 | |
| June 30, 2013 | 1.085M |
| December 31, 2012 | 1.187M |
| June 30, 2012 | 1.174M |
| December 31, 2011 | 0.9213M |
| June 30, 2011 | 1.719M |
| December 31, 2010 | -1.551M |
| June 30, 2010 | 1.715M |
| December 31, 2009 | 8.761M |
| June 30, 2009 | 7.961M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
0.0005M
Minimum
Jun 2019
0.0005M
Maximum
Jun 2019
0.0005M
Average
0.0005M
Median
Jun 2019
Revenue (TTM) Benchmarks
| Immutep Ltd | 5.113M |
| Opthea Ltd | 0.1171M |
| Alterity Therapeutics Ltd | -0.0416M |
| Mesoblast Ltd | 7.501M |
| Immuron Ltd | 2.349M |